Cliantha Research Limited
FDA inspection history in Ahmedabad, India, 2026
- 1
- Form 483
Every document, by year
- Form 483
2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2026One Form 483, at Ahmedabad, India.
Cited most
Across all Cliantha Research Limited observations on file
- 21 CFR 320.38Retention of bioavailability samples1
- 21 CFR 50.20General requirements for informed consent1
- 21 CFR 50.25Elements of informed consent1
The complete Cliantha Research Limited file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Ahmedabad, India
One Form 483 · 2026 · 6 observations
Latest: Form 483, Apr 17, 2026 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-04-17 | 483 Form 483 | Ahmedabad, India | 6 | $99 |
Investigators on these documents
Anna M. Brannen (1)Kara A. Scheibner (1)Koffi A. Amegadje (1)Miguel A. Martinez (1)
FEI number 3017682080 · most recent document Apr 17, 2026
About Cliantha Research Limited
How many FDA Form 483s has Cliantha Research Limited received?
FDA Intel has 1 Form 483 on file for Cliantha Research Limited; the most recent is dated Apr 17, 2026.
When was Cliantha Research Limited last inspected by FDA?
The most recent FDA inspection document on file for Cliantha Research Limited is a Form 483 dated Apr 17, 2026, for the site in Ahmedabad, India.
What did FDA cite at Cliantha Research Limited?
The regulations cited most in the observations on file for Cliantha Research Limited are 21 CFR 320.38 (Retention of bioavailability samples), 1 time; 21 CFR 50.20 (General requirements for informed consent), 1 time; 21 CFR 50.25 (Elements of informed consent), 1 time.